At the concluding event of the 2014 Dean’s Health & Life Science Challenge, Aldatu Biosciences was selected as the winner of the inaugural Bertarelli Prize – an impressive achievement for a young company with huge potential.
Aldatu Biosciences was founded at the iLab by David Raiser and Iain MacLeod to further their efforts to apply PANDAA (Pan-Degenerate Amplification and Adaptation) technology to the challenge of detecting drug resistant strains of HIV. PANDAA is a familiar technology to many in the scientific community but Aldatu Bioscience have applied it in a novel way to great effect.
Drug resistance is already a huge problem and Iain McLeod be believes the problem is only getting worse:
“Year on year, both transmitted and acquired resistance to HIV antiretroviral is increasing around the world. When a Botswana Harvard AIDS Institute study started in 2010, about 4 per cent. of women who were coming into antenatal clinics had resistance. Now it’s up to 10 per cent.”
Aldatu Biosciences are entering an exciting stage of their development and intend to use their prize to help further their existing relationships with health professionals in East Africa where there is urgent need for improved detection of drug resistance.
The Bertarelli Foundation is a keen supporter of entrepreneurs in the life science sector, and especially those that can make practical improvements to the health and well-being of large numbers of people. Aldatu Biosciences is an excellent example of a young company with big ideas and the drive and desire to make a difference.